JNJ
Johnson & Johnson
Company · XNYS · US · USD
Market price
$271.33
+$26.48 (+10.82%) · 3 months
| Date and time | Price |
|---|---|
| Jun 25, 2026 | $244.84 |
| Jun 26, 2026 | $254.41 |
| Jun 29, 2026 | $258.51 |
| Jun 30, 2026 | $253.91 |
| Jul 1, 2026 | $253.13 |
| Jul 2, 2026 | $262.94 |
| Jul 6, 2026 | $259.33 |
| Jul 7, 2026 | $267.24 |
| Jul 8, 2026 | $263.33 |
| Jul 9, 2026 | $259.11 |
| Jul 10, 2026 | $257.20 |
| Jul 13, 2026 | $257.77 |
| Jul 14, 2026 | $253.77 |
| Jul 15, 2026 | $246.99 |
| Jul 16, 2026 | $249.59 |
| Jul 17, 2026 | $253.02 |
| Jul 20, 2026 | $248.82 |
| Jul 21, 2026 | $250.73 |
| Jul 22, 2026 | $255.69 |
| Jul 23, 2026 | $259.39 |
| Jul 24, 2026 | $263.44 |
| Jul 27, 2026 | $265.95 |
| Jul 28, 2026 | $266.68 |
| Jul 29, 2026 | $265.66 |
| Jul 30, 2026 | $255.88 |
| Jul 31, 2026 | $256.41 |
| Aug 3, 2026 | $254.41 |
| Aug 4, 2026 | $254.99 |
| Aug 5, 2026 | $257.62 |
| Aug 6, 2026 | $257.14 |
| Aug 7, 2026 | $259.28 |
| Aug 10, 2026 | $261.81 |
| Aug 11, 2026 | $259.70 |
| Aug 12, 2026 | $260.86 |
| Aug 13, 2026 | $262.08 |
| Aug 14, 2026 | $260.36 |
| Aug 17, 2026 | $262.37 |
| Aug 18, 2026 | $271.05 |
| Aug 19, 2026 | $273.37 |
| Aug 20, 2026 | $267.67 |
| Aug 21, 2026 | $270.31 |
| Aug 24, 2026 | $273.04 |
| Aug 25, 2026 | $273.16 |
| Aug 26, 2026 | $270.00 |
| Aug 27, 2026 | $265.75 |
| Aug 28, 2026 | $268.04 |
| Aug 31, 2026 | $265.85 |
| Sep 1, 2026 | $271.19 |
| Sep 2, 2026 | $275.21 |
| Sep 3, 2026 | $278.43 |
| Sep 4, 2026 | $275.23 |
| Sep 8, 2026 | $269.12 |
| Sep 9, 2026 | $267.08 |
| Sep 10, 2026 | $266.35 |
| Sep 11, 2026 | $265.58 |
| Sep 14, 2026 | $266.32 |
| Sep 15, 2026 | $267.20 |
| Sep 16, 2026 | $267.28 |
| Sep 17, 2026 | $270.22 |
| Sep 18, 2026 | $269.99 |
| Sep 21, 2026 | $269.47 |
| Sep 22, 2026 | $269.19 |
| Sep 23, 2026 | $269.17 |
| Sep 24, 2026 | $271.33 |
- Period change
- +10.82%
- Period low
- $244.84
- Period high
- $278.43
- Observations
- 64
- Updated
- Sep 24, 2026, 8:00 PM
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Company websiteClassifications
- Biotechnology · Biotech
- Consumer staple goods · Necessities
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $649,395,374,933.59
- Employees
- 140.8K